Biochemical effects of chronic abuse of ergogenic aids in rats

To investigate the potential health risks associated with recommended or overdoses of amino acids mixture such as Power Mix [PM], Branched Chain Amino Acids [BCAAs] or Ceratine [Cr] supplementation as ergogenic aids for short or long-term rats. Male Sprague Dawley rats were assigned into two major groups; the first group was orally treated with the above mentioned supplements for six weeks [short-term], and the second group was treated similarly but for twelve weeks [long-term]. Each of the short- and long-term group was subdivided into seven subgroups which were treated as follows: PM [0.8 g/kg/day], PM [2.4 g/kg/day], BCAAs [0.2 g/kg/day]. BCAAs 0.6 g/kg/day], Cr [2 g/kg/day], Cr [6 g/kg/day] and controls [kept without treatment]. Plasma amino acids levels beside renal, thyroid, adrenal, and hepatic functions were estimated. Significant elevation in total amino acids concentration was found as result of feeding with the three dietary supplements. Results showed significant increase in serum creatinine level in rats ingested with these ergogenic aids except the low dose of PM given for short- or long-term. High doses of the three supplements given for both short- and long-term and low doses of BCAAs and Cr given for long-term caused significant elevation in serum uric acid level. Significant increase in serum NAG activity was observed among the three dietary supplements. Also, significant rise in serum AST and ALT activities was obtained after feeding the three dietary supplements except the low dose of PM given for short-term. Serum T3 level was significantly increased by feeding BCAAs or Cr in high doses for long-term. None of the three supplements exerted significant change in serum TSH and T4 levels. High doses of PM, BCAAs or Cr given for either short- or long-term caused significant increase in serum corticosterone and significant decrease in plasma ACTH levels. The three dietary supplements resulted in significant increase in cytosolic AST and ALT activities except the low dose of PM given for short- and long-term as well as low dose of BCAAs and Cr given for short-term. The three dietary supplement except low dose of PM fed for short-term, caused significant rise in mitochondrial AST activity. This study showed that supplementation of high-dose of PM, BCAAs or Cr given for long-term as ergogenic aids induced renal and hepatic damage as well hormonal disturbances

Some biochemical screening tests of metabolic disorders in Egyptian children suffering mental retardation

The present study deals with investigation of the biochemical abnormality and the metabolic disorders which may be the cause or contribute significantly to the cause of mental retardation [MR]. The study included 203 mentally retarded children who were subjected to qualitative chemical tests on urine for the detection of certain defects in amino acid and carbohydrate metabolism. Thin layer chromatographic detection of specific amino acids in plasma and urine, and the quantitative determination of urea, creatinine, ammonia and uric acid in plasma, argininosuccinase and argininase enzyme activities in erythrocytes; mucopolysaccharides and creatinine in urine were also investigated. It was found that in 92 patient, mental retardation is accompanied by metabolic disorders. These comprise disorders in amino acid transport [10.6%] urea cycle abnormalities [17.4%], generalized amino acid urea [10.8%], miscellaneous aminoacidopathies [25%] and defects in carbohydrate metabolism [26.1%]. The plasma levels of urea, uric acid and creatinine in patients with disorders in aminoacid transport were unchanged indicating normal kidney function. Patients with urea cycle abnormalities showed deficiency in different enzymes controlling urea formation with elevation in plasma ammonia and decrease in plasma urea. Patient with carbohydrate metabolism disorders showed increased urinary mucopolysaccharides. These metabolic disorders were discussed on the basis of the findings obtained and the genetic defect that led to the respective metabolic disorder. According to results of this work, it is highly recommended to carry out genetic counselling in calculating the possibilities for recurrence risk of hereditary disorders and in detecting any metabolic abnormality to prevent the onset of mental retardation. Early detection of these cases and evaluation of specific treatment will be valuable for the management of these cases